Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKinsey
AstraZeneca
US Department of Justice
Merck
Fuji
Cantor Fitzgerald
Colorcon
Federal Trade Commission

Generated: May 23, 2018

DrugPatentWatch Database Preview

VALNAC Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Valnac, and what generic alternatives are available?

Valnac is a drug marketed by Actavis Mid Atlantic and is included in one NDA.

The generic ingredient in VALNAC is betamethasone valerate. There are sixty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Drug patent expirations by year for VALNAC
Pharmacology for VALNAC
Medical Subject Heading (MeSH) Categories for VALNAC
Synonyms for VALNAC
(11.beta.,16.beta.)-9.alpha.-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17.alpha.-valerate
(11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate
(1R,2S,10S,11S,13S,14R,15S,17S)-1-FLUORO-17-HYDROXY-14-(2-HYDROXYACETYL)-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL PENTANOATE
(2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13, 15-trimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl pe ntanoate
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl p
[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate
1,4-Pregnadiene-11beta,17alpha,21-triol-9alpha-fluoro-16beta-methyl-3,20-dione 17-valerate
12772-60-0
149665-14-5
152M445
2152-44-5
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-17-valerate
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate
9-Fluoro-11.beta.,21-dihydroxy-16.beta.-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate #
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17-valerate
9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate
9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate
944728-94-3
9alpha-Fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 17-valerate
9alpha-Fluoro-16beta-methylprednisolone 17-valerate
9IFA5XM7R2
AB01274710_02
AB01274710-01
AB2000222
AC1L285F
AKOS015994704
AN-14218
Bedermin
beta-Methasone 17-valerate
beta-Val
Beta-Val (TN)
Betaderm
Betamethason-17-valerate
Betamethasone 17-valerate
Betamethasone 17a-valerate
Betamethasone 17alpha-valerate
BETAMETHASONE VALERATE
Betamethasone Valerate (Betamethasone 17-Valerate)
Betamethasone valerate (Betnovate)
Betamethasone valerate (JP17/USP)
Betamethasone valerate [USAN:BAN:JAN]
Betamethasone valerate [USAN:USP:JAN]
Betamethasone-17-valerate
Betatrex
Betatrex (Salt/Mix)
Betaval
Betnesol V
Betnesol-V
Betneval
Betnovate
Betnovate;Celestone;Betaderm;Luxiq
Betnovateat
Betoid
Bettamousse
Bextasol
C27H37FO6
CAS-2152-44-5
Celestan V
Celestan-V
Celestane V
Celestoderm
Celestoderm-V
Celeston valerate
CHEBI:31277
CHEMBL1497
Chlorophytum Borivilanum
D01357
D03SXE
Dermosol
Dermovaleas
DR002949
DSSTox_CID_2673
DSSTox_GSID_22673
DSSTox_RID_76684
DTXSID7022673
Ecoval 70
EINECS 218-439-3
entanoate
Flubenisolonvalerate
Fuciderm
Gentocin (Salt/Mix)
Gentocin (Veterinary)
KS-1198
LS-118456
Luxiq
Luxiq (TN)
MFCD00867446
MolPort-003-933-651
NCGC00255185-01
NCGC00274064-01
PL043955
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-,(11-beta,16-beta)-
Rinderon V
Rinderon-V (TN)
RL02645
s1690
SCHEMBL7270
SNHRLVCMMWUAJD-SUYDQAKGSA-N
ST075178
Stanoval
Tokuderm
Topagen (Salt/Mix)
Topagen (Veterinary)
Tox21_302288
UNII-9IFA5XM7R2
ZINC3882052

US Patents and Regulatory Information for VALNAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic VALNAC betamethasone valerate CREAM;TOPICAL 070050-001 Oct 10, 1984 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Merck
Farmers Insurance
Covington
Cipla
Mallinckrodt
US Department of Justice
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.